Sign inJoin waitlistJoin the waitlist

Jeffrey D. Aldrich

Medical Oncology · Unc Physicians and Associates

Credentials: · · ·

History

Research

Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint Inhibitors
Arthritis & Rheumatology · 2021 · First of 9 authors · 96 citations
Spatially variant immune infiltration scoring in human cancer tissues
npj Precision Oncology · 2022 · 37 citations
A systematic review and meta-analysis of observational studies and uncontrolled trials reporting on the use of checkpoint blockers in patients with cancer and pre-existing…
Systematic review or meta-analysis · European Journal of Cancer · 2024 · 36 citations

MS
Mahran Shoukier
3 papers · 3 as a fellow
Manali Bhave
3 papers
Maria Suarez-Almazor
3 papers
Sudhakar Tummala
2 papers
Alyssa Mohammed
1 paper
Anita Deswal
1 paper
Cesar Simbaqueba
1 paper
Courtney DiNardo
1 paper
Dana Casey
1 paper
Ed Kheder
1 paper
Elizabeth Dees
1 paper
Ellen Jones
1 paper

Clinical trials

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Site PI · Recruiting · Phase 2
Eli Lilly and Company
2026–2029
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037